Determination of ranitidine in plasma by high-performance liquid chromatography

A high-performance liquid chromatographic method has been developed for the determination of ranitidine in plasma. Ranitidine was extracted with acetonitrile by adding it to the plasma and then salting it out with potassium carbonate. The chromatographic column was 5-μm ODS silica, the mobile phase...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of pharmaceutical and biomedical analysis 1989, Vol.7 (6), p.747-753
Hauptverfasser: Rahman, Asirur, Hoffman, Norman E., Rustum, Abu M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 753
container_issue 6
container_start_page 747
container_title Journal of pharmaceutical and biomedical analysis
container_volume 7
creator Rahman, Asirur
Hoffman, Norman E.
Rustum, Abu M.
description A high-performance liquid chromatographic method has been developed for the determination of ranitidine in plasma. Ranitidine was extracted with acetonitrile by adding it to the plasma and then salting it out with potassium carbonate. The chromatographic column was 5-μm ODS silica, the mobile phase being acetonitrile-7 mM triethylammonium ion in phosphoric acid (pH 3.00) (30:70 v/v). The ranitidine peak was monitored at a wavelength of 315 nm, the retention time for ranitidine being 4.6 min. A limit of detection of 3 ng ml −1 was obtained for a 100-μl injection of ranitidine. The method was found to be reproducible with a relative standard deviation (RSD) between 0.8–5.3% ( n = 5) over the concentration range 25–80 ng ml −1 in plasma. The ranitidine concentration was determined in 18 different patients' plasmas. Ranitidine and its metabolites ranitidine S-oxide, ranitidine N-oxide and desmethylranitidine, were also studied for chromatographic resolution from each other. It was shown that a group of common drugs did not interfere with ranitidine determination.
doi_str_mv 10.1016/0731-7085(89)80119-0
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79580222</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0731708589801190</els_id><sourcerecordid>79580222</sourcerecordid><originalsourceid>FETCH-LOGICAL-c386t-33ce923711efa8a082d1ccb6d7be166a1238fa9bbc941f49dfe855532c3a827e3</originalsourceid><addsrcrecordid>eNp9kEtL5EAUhQtxaNvHP1DIQkQXGeuRpKo2gjg6MyD0RsFdcVO5ZZckqViVHuh_P2m76aWruzjfOVw-Qs4Z_ckoq26pFCyXVJXXSt8oypjO6QGZMyVFzqvi7ZDM98gROU7pg1JaMl3MyIwXmkop52TxC0eMne9h9KHPgssi9H70je8x8302tJA6yOp1tvTvy3zA6ELsoLeYtf5z5ZvMLmPoYAzvEYbl-pT8cNAmPNvdE_L69Pjy8Cd_Xvz--3D_nFuhqjEXwqLmQjKGDhRQxRtmbV01skZWVcC4UA50XVtdMFfoxqEqy1JwK0BxieKEXG13hxg-V5hG0_lksW2hx7BKRupSUc75BBZb0MaQUkRnhug7iGvDqNl4NBtJZiPJKG2-PBo61S52-6u6w2Zf2omb8stdDslC6yZr1qc9JkWplN7M3G0xnFz88xhNsh4ne42PaEfTBP_9H_8BLDKPjg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79580222</pqid></control><display><type>article</type><title>Determination of ranitidine in plasma by high-performance liquid chromatography</title><source>Elsevier ScienceDirect Journals Complete - AutoHoldings</source><source>MEDLINE</source><creator>Rahman, Asirur ; Hoffman, Norman E. ; Rustum, Abu M.</creator><creatorcontrib>Rahman, Asirur ; Hoffman, Norman E. ; Rustum, Abu M.</creatorcontrib><description>A high-performance liquid chromatographic method has been developed for the determination of ranitidine in plasma. Ranitidine was extracted with acetonitrile by adding it to the plasma and then salting it out with potassium carbonate. The chromatographic column was 5-μm ODS silica, the mobile phase being acetonitrile-7 mM triethylammonium ion in phosphoric acid (pH 3.00) (30:70 v/v). The ranitidine peak was monitored at a wavelength of 315 nm, the retention time for ranitidine being 4.6 min. A limit of detection of 3 ng ml −1 was obtained for a 100-μl injection of ranitidine. The method was found to be reproducible with a relative standard deviation (RSD) between 0.8–5.3% ( n = 5) over the concentration range 25–80 ng ml −1 in plasma. The ranitidine concentration was determined in 18 different patients' plasmas. Ranitidine and its metabolites ranitidine S-oxide, ranitidine N-oxide and desmethylranitidine, were also studied for chromatographic resolution from each other. It was shown that a group of common drugs did not interfere with ranitidine determination.</description><identifier>ISSN: 0731-7085</identifier><identifier>EISSN: 1873-264X</identifier><identifier>DOI: 10.1016/0731-7085(89)80119-0</identifier><identifier>PMID: 2490777</identifier><identifier>CODEN: JPBADA</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Analysis ; Biological and medical sciences ; Chromatography, High Pressure Liquid ; determination in plasma ; Drug Stability ; General pharmacology ; high-performance liquid chromatography ; Humans ; Medical sciences ; Molecular Structure ; Pharmacology. Drug treatments ; Ranitidine ; Ranitidine - blood ; ranitidine metabolites ; Reproducibility of Results ; Sensitivity and Specificity</subject><ispartof>Journal of pharmaceutical and biomedical analysis, 1989, Vol.7 (6), p.747-753</ispartof><rights>1989</rights><rights>1989 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c386t-33ce923711efa8a082d1ccb6d7be166a1238fa9bbc941f49dfe855532c3a827e3</citedby><cites>FETCH-LOGICAL-c386t-33ce923711efa8a082d1ccb6d7be166a1238fa9bbc941f49dfe855532c3a827e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/0731708589801190$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,4009,27902,27903,27904,65309</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=7358890$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2490777$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rahman, Asirur</creatorcontrib><creatorcontrib>Hoffman, Norman E.</creatorcontrib><creatorcontrib>Rustum, Abu M.</creatorcontrib><title>Determination of ranitidine in plasma by high-performance liquid chromatography</title><title>Journal of pharmaceutical and biomedical analysis</title><addtitle>J Pharm Biomed Anal</addtitle><description>A high-performance liquid chromatographic method has been developed for the determination of ranitidine in plasma. Ranitidine was extracted with acetonitrile by adding it to the plasma and then salting it out with potassium carbonate. The chromatographic column was 5-μm ODS silica, the mobile phase being acetonitrile-7 mM triethylammonium ion in phosphoric acid (pH 3.00) (30:70 v/v). The ranitidine peak was monitored at a wavelength of 315 nm, the retention time for ranitidine being 4.6 min. A limit of detection of 3 ng ml −1 was obtained for a 100-μl injection of ranitidine. The method was found to be reproducible with a relative standard deviation (RSD) between 0.8–5.3% ( n = 5) over the concentration range 25–80 ng ml −1 in plasma. The ranitidine concentration was determined in 18 different patients' plasmas. Ranitidine and its metabolites ranitidine S-oxide, ranitidine N-oxide and desmethylranitidine, were also studied for chromatographic resolution from each other. It was shown that a group of common drugs did not interfere with ranitidine determination.</description><subject>Analysis</subject><subject>Biological and medical sciences</subject><subject>Chromatography, High Pressure Liquid</subject><subject>determination in plasma</subject><subject>Drug Stability</subject><subject>General pharmacology</subject><subject>high-performance liquid chromatography</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Molecular Structure</subject><subject>Pharmacology. Drug treatments</subject><subject>Ranitidine</subject><subject>Ranitidine - blood</subject><subject>ranitidine metabolites</subject><subject>Reproducibility of Results</subject><subject>Sensitivity and Specificity</subject><issn>0731-7085</issn><issn>1873-264X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1989</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEtL5EAUhQtxaNvHP1DIQkQXGeuRpKo2gjg6MyD0RsFdcVO5ZZckqViVHuh_P2m76aWruzjfOVw-Qs4Z_ckoq26pFCyXVJXXSt8oypjO6QGZMyVFzqvi7ZDM98gROU7pg1JaMl3MyIwXmkop52TxC0eMne9h9KHPgssi9H70je8x8302tJA6yOp1tvTvy3zA6ELsoLeYtf5z5ZvMLmPoYAzvEYbl-pT8cNAmPNvdE_L69Pjy8Cd_Xvz--3D_nFuhqjEXwqLmQjKGDhRQxRtmbV01skZWVcC4UA50XVtdMFfoxqEqy1JwK0BxieKEXG13hxg-V5hG0_lksW2hx7BKRupSUc75BBZb0MaQUkRnhug7iGvDqNl4NBtJZiPJKG2-PBo61S52-6u6w2Zf2omb8stdDslC6yZr1qc9JkWplN7M3G0xnFz88xhNsh4ne42PaEfTBP_9H_8BLDKPjg</recordid><startdate>1989</startdate><enddate>1989</enddate><creator>Rahman, Asirur</creator><creator>Hoffman, Norman E.</creator><creator>Rustum, Abu M.</creator><general>Elsevier B.V</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1989</creationdate><title>Determination of ranitidine in plasma by high-performance liquid chromatography</title><author>Rahman, Asirur ; Hoffman, Norman E. ; Rustum, Abu M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c386t-33ce923711efa8a082d1ccb6d7be166a1238fa9bbc941f49dfe855532c3a827e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1989</creationdate><topic>Analysis</topic><topic>Biological and medical sciences</topic><topic>Chromatography, High Pressure Liquid</topic><topic>determination in plasma</topic><topic>Drug Stability</topic><topic>General pharmacology</topic><topic>high-performance liquid chromatography</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Molecular Structure</topic><topic>Pharmacology. Drug treatments</topic><topic>Ranitidine</topic><topic>Ranitidine - blood</topic><topic>ranitidine metabolites</topic><topic>Reproducibility of Results</topic><topic>Sensitivity and Specificity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rahman, Asirur</creatorcontrib><creatorcontrib>Hoffman, Norman E.</creatorcontrib><creatorcontrib>Rustum, Abu M.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pharmaceutical and biomedical analysis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rahman, Asirur</au><au>Hoffman, Norman E.</au><au>Rustum, Abu M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Determination of ranitidine in plasma by high-performance liquid chromatography</atitle><jtitle>Journal of pharmaceutical and biomedical analysis</jtitle><addtitle>J Pharm Biomed Anal</addtitle><date>1989</date><risdate>1989</risdate><volume>7</volume><issue>6</issue><spage>747</spage><epage>753</epage><pages>747-753</pages><issn>0731-7085</issn><eissn>1873-264X</eissn><coden>JPBADA</coden><abstract>A high-performance liquid chromatographic method has been developed for the determination of ranitidine in plasma. Ranitidine was extracted with acetonitrile by adding it to the plasma and then salting it out with potassium carbonate. The chromatographic column was 5-μm ODS silica, the mobile phase being acetonitrile-7 mM triethylammonium ion in phosphoric acid (pH 3.00) (30:70 v/v). The ranitidine peak was monitored at a wavelength of 315 nm, the retention time for ranitidine being 4.6 min. A limit of detection of 3 ng ml −1 was obtained for a 100-μl injection of ranitidine. The method was found to be reproducible with a relative standard deviation (RSD) between 0.8–5.3% ( n = 5) over the concentration range 25–80 ng ml −1 in plasma. The ranitidine concentration was determined in 18 different patients' plasmas. Ranitidine and its metabolites ranitidine S-oxide, ranitidine N-oxide and desmethylranitidine, were also studied for chromatographic resolution from each other. It was shown that a group of common drugs did not interfere with ranitidine determination.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>2490777</pmid><doi>10.1016/0731-7085(89)80119-0</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0731-7085
ispartof Journal of pharmaceutical and biomedical analysis, 1989, Vol.7 (6), p.747-753
issn 0731-7085
1873-264X
language eng
recordid cdi_proquest_miscellaneous_79580222
source Elsevier ScienceDirect Journals Complete - AutoHoldings; MEDLINE
subjects Analysis
Biological and medical sciences
Chromatography, High Pressure Liquid
determination in plasma
Drug Stability
General pharmacology
high-performance liquid chromatography
Humans
Medical sciences
Molecular Structure
Pharmacology. Drug treatments
Ranitidine
Ranitidine - blood
ranitidine metabolites
Reproducibility of Results
Sensitivity and Specificity
title Determination of ranitidine in plasma by high-performance liquid chromatography
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T01%3A01%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Determination%20of%20ranitidine%20in%20plasma%20by%20high-performance%20liquid%20chromatography&rft.jtitle=Journal%20of%20pharmaceutical%20and%20biomedical%20analysis&rft.au=Rahman,%20Asirur&rft.date=1989&rft.volume=7&rft.issue=6&rft.spage=747&rft.epage=753&rft.pages=747-753&rft.issn=0731-7085&rft.eissn=1873-264X&rft.coden=JPBADA&rft_id=info:doi/10.1016/0731-7085(89)80119-0&rft_dat=%3Cproquest_cross%3E79580222%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79580222&rft_id=info:pmid/2490777&rft_els_id=0731708589801190&rfr_iscdi=true